Home
Synthon

Synthon Market Share Analysis for November 2025

Synthon is a Dutch multinational that produces generic human drugs. The company was founded in 1991 by Jacques Lemmens and Marijn Oosterbaan, two organic chemists of the Radboud University Nijmegen.

Health > Biotechnology and Pharmaceuticals

Domainsynthon.com

Year Founded1991

Employees1001 - 5000

Annual Revenue$200M - $500M

Synthon

Synthon (including company regionals)

synthon.com

See more website traffic and engagement information

Synthon Revenue up to November 2025 is 200M - 500M

revenue generated by Synthon top domains

Synthon top domains revenue over 3 years

Revenue for Synthon top domains

synthon.com200M - 500M

See more with Sales Intelligence

Total visits to Synthon's top domains

Understand Synthon market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

synthon.com12.8K

See more with Sales Intelligence

Avg. visit duration in Synthon's top domains

Analyze Synthon engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

synthon.com00:01:10

See more with Sales Intelligence

Avg. pageviews on Synthon's top domains

See how Synthon keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

synthon.com2.05

See more with Sales Intelligence

Synthon top competitors by domain

Top similar sites in November 2025, ranked by their affinity

astrazeneca.nlCompany NameAstraZenecaEmployees> 10001HQUnited Kingdom, CambridgeAnnual revenue> $1BTotal visits7.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Synthon

These are the website technologies, by industry, used by Synthon top domains

Social (4)

Instagram

Advertising (3)

DoubleClick

Widget (3)

reCAPTCHA

Content Management System (2)

Web Dot Com

More Technologies

8

See all

News & Signals from Synthon

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSynthon recognized as Top Employers Spain.Among 108 companies, Synthon Hispania has been certified as Top Employers Spain.

NewsGoldman Sachs Asset Managemen acquires Synthon for $2.08B.Goldman Sachs Asset Management has agreed a more than €2bn deal to acquire drugmaker Synthon from BC Partners, according to people familiar with the matter, as it hopes to capitalise on demand for off-patent versions of complex medicines.

NewsSynthon received award Silver Medal on Jan 1st '24.Synthon, is proud to announce that it has been awarded the prestigious Silver Medal in this year's EcoVadis sustainability assessment, reflecting the company's unwavering commitment to responsible business practices and environmental stewardship.